4 to 6 -week-old female BALB/c mice were obtained from Charles River Laboratories (Washington, MA) and housed according to a protocol approved by the University of Rochester Council on Animal Research. This study adhered to guidelines outlined in the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. The mice were anesthetized with 100 mg/kg ketamine (Par Pharmaceutical, Chestnut Ridge, NY) and 10 mg/kg xylazine (Akorn, Inc., Lake Forest, IL), and 0.5% proparacaine (Akorn, Inc., Lake Forest, IL) was applied to the right eye of each mouse. A 27-gauge needle was used to create three parallel 1-mm scratches across the central right corneal epithelium and anterior stroma. Eyes were subsequently inoculated with 5ul of S. aureus bacterial culture containing 107 colony forming units (CFU). At 48 hours post infection, slit lamp biomicroscopy (Topcon SL-8Z with attached Nikon D80 digital camera) was used to evaluate each infection and a post-doctoral student (WJ) assigned a clinical severity score using the Hazlett et al. grading scheme: 0, no corneal opacity; 1, faint corneal opacity; 2, dense corneal opacity overlying pupil; 3, dense corneal opacity covering entire cornea; 4, corneal perforation. SLP images were obtained for quantitative analysis. A certified ophthalmic photographer performed all imaging with defined camera settings (camera setting mode: manual, shutter speed setting: 60, optimize image setting: professional, image quality setting: normal, image file size setting: normal, while balance setting: automatic, sensor sensitivity setting: ISO 1000, noise reduction setting: off, sensor sensitivity sub setting: normal, multiple exposure setting: off) and under diffuse slit lamp lighting. Mice with grade 0 infections were excluded due to the lack of SI to annotate, and grade 4 infections were not observed. Animals were subsequently euthanized, and eyes enucleated for quantification of ocular bacterial burden.